Rethinking Clinical Trials

JANUARY 17, 2024

The first monoclonal antibody (mABs) treatment for treatment of COVID-19 was approved in November 2020. Clinicians wrote a consult for mABs and the pharmacy delivered whichever mAB that was available. When Evusheld was approved in December 2021 a similar weighted lottery process was put into place.

Clinical Trials 169

Clinical Trials Clinical Trials Antibody Trials 169

Drug Discovery World

OCTOBER 28, 2022

Click’ chemistry used to tag proteins made by cancer cells . A panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) have been shown to block infection when tested in human cells in a laboratory setting. . . Millions invited to join UK’s largest health research programme .

Drugs 52

Drugs Antibody Protein RNA 52

Drug Discovery World

NOVEMBER 13, 2023

Laura Mele, PhD, Investigator, GlaxoSmithKline, on: ‘Discovery and characterisation of highly potent Fc-enhanced anti-GPCR mAbs’. Fabian Mohr, PhD, Vice President Research & Development, IBA Lifesciences, on: ‘Developing a robust affinity tag platform using engineered streptavidin’.

Protein 59

Protein Antibody Engineer Scientist 59

The Pharma Data

MAY 5, 2021

New variant-hardy AbCellera-Lilly mAb shows utility of viral genomics surveillance ( BioCentury ). AbbVie’s Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along ( Fierce ). The weird science of the placebo effect keeps getting more interesting ( Vox ).

Vaccination 52

Vaccination Vaccine Gene Therapy Contract Packaging 52